Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Karuna Therapeutics, Inc. from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Karuna Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q1 2020 to Q4 2023.
  • Karuna Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2023 was $18.5M, a 4393% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Karuna Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $18.5M +$18.1M +4393% 31 Dec 2023 10-K 22 Feb 2024
Q3 2023 $18.9M +$18.4M +3732% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $19.3M +$18.7M +3226% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $339K -$338K -49.9% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $411K -$372K -47.5% 31 Dec 2022 10-K 23 Feb 2023
Q3 2022 $492K -$402K -45% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $580K -$434K -42.8% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $677K +$469K +225% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $783K +$537K +218% 31 Dec 2021 10-K 24 Feb 2022
Q3 2021 $894K +$605K +209% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $1.01M +$731K +258% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $208K -$115K -35.6% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $246K 31 Dec 2020 10-K 25 Feb 2021
Q3 2020 $289K 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $283K 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $323K 31 Mar 2020 10-Q 07 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.